ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 32 filers reported holding ARGENX SE in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $589,000 | -39.6% | 4,471 | -26.4% | 0.25% | -26.6% |
| Q4 2019 | $975,000 | -61.1% | 6,071 | -72.4% | 0.34% | -64.4% |
| Q3 2019 | $2,504,000 | -44.3% | 21,969 | -30.8% | 0.94% | -44.3% |
| Q2 2019 | $4,495,000 | +1.0% | 31,750 | -10.9% | 1.69% | -12.0% |
| Q1 2019 | $4,451,000 | -20.5% | 35,650 | -38.9% | 1.92% | -31.1% |
| Q4 2018 | $5,601,000 | +14.8% | 58,300 | -9.3% | 2.78% | +39.0% |
| Q3 2018 | $4,877,000 | +126.8% | 64,300 | +147.8% | 2.00% | +98.9% |
| Q2 2018 | $2,150,000 | -54.0% | 25,949 | -55.4% | 1.01% | -55.7% |
| Q1 2018 | $4,676,000 | -22.4% | 58,130 | -39.1% | 2.28% | -29.9% |
| Q4 2017 | $6,023,000 | +566.3% | 95,396 | +138.5% | 3.24% | +478.3% |
| Q3 2017 | $904,000 | +6.6% | 40,000 | 0.0% | 0.56% | -7.3% |
| Q2 2017 | $848,000 | – | 40,000 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |